Similarly, in A549 human lung cancer cell lines, Curcumin downregulated NF-κB activity and acted on the JAK2/STAT3 signaling pathway by suppressing JAK2 activity; thus, Curcumin is a successful therapeutic drug for treating lung cancer [92]. This evidence concerns the gene JAK2 and lung carcinoma.